Table:
begin	end	state
1	34	cytoplasmic
35	57	transmembrane
58	68	non-cytoplasmic
69	89	transmembrane
90	112	cytoplasmic
113	134	transmembrane
135	153	non-cytoplasmic
154	173	transmembrane
174	184	cytoplasmic
185	205	transmembrane
206	216	non-cytoplasmic
217	240	transmembrane
241	251	cytoplasmic
252	275	transmembrane
276	303	non-cytoplasmic
304	328	transmembrane
329	347	cytoplasmic
348	368	transmembrane
369	373	non-cytoplasmic
374	392	transmembrane
393	412	cytoplasmic
413	435	transmembrane
436	437	non-cytoplasmic

Input:
>WP_012412234.1 NCBI__GCF_000020025.1:WP_012412234.1
MLPIETVLKDSEQVTRLFSHLEFDGKKFNHQPGSVLGSTALIAGTTVGAGILALPAVTLP
SGIVPSTSGLIAVWLYALVSGLLVAEVTLNTMRTEGRVSIGFLGVVEKILGKLGAQMAGG
AYLFMHYALLVAYITQGGEILGYAAAKIWSVQILPAWMGTTTFTLLFGGIMYLGREKFIE
KLNSAFVGIVIVSFFGLLFFAGRHIQSAQLLFQNWSALGSAISVMSVALFFQNVVPLVVT
QLEGDAGKIRQSILIGSVIPLIMFLAWNAVILGSISPDMQYGTSDGRTVFDPLQILRAGG
AGEWLGVLVSIFSEFAIVTSFIGFVYGLLDLFEDIFLGQSKLSNRFPLYSLVLFPPMTLG
TLNPSIFFTALDYTGTFSISVLGGIIPALMSWKQRQEQENSDSTNQLLVPGGKLTLIVMI
GVALTMMGRQILVIYTE

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server